Catalyst Wire Dossier Catalyst Wire Dossier

Abilar

· Repolar Pharmaceuticals Oy
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Abilar, covering 2025-02-06 to 2025-02-06. Get the full timeline:

Most recent: Clinical Trial Update: HRIPT Study to Evaluate the Irritation and Allergenic Potential of Medical-grade Norway Spruce (Picea Abies) Resin Salve (Abilar) [NA]

See pricing